Tobacco Treatment Guideline Use and Predictors Among U.S. Physicians by Specialty.
Tobacco Treatment Guideline Use and Predictors Among U.S. Physicians by Specialty.
复制标题
DOI:
10.1016/j.amepre.2021.05.014
复制
发表时间:
2021-12
影响因子:
5.5
通讯作者:
Delnevo CD
中科院分区:
文献类型:
--
作者:
Schaer DA;Singh B;Steinberg MB;Delnevo CD
Physicians play a critical role in tobacco treatment, being a frequent link to smokers and a trusted source of information. Unfortunately, barriers exist that limit physicians’ implementation of evidence-based interventions. This study examines the implementation and predictors of the “5A’s” tobacco treatment clinical guidelines among U.S. physicians. A national sample of 1,058 U.S. physicians from 6 specialties (Family Medicine, Internal Medicine, Obstetrics and Gynecology, Cardiology, Pulmonology, and Oncology) were surveyed in 2018 (51.8% response rate). Survey domains included: demographics, awareness of guidelines, tobacco treatment practices (i.e., 5A’s), perceived barriers to treatment, and perceived efficacy of various treatments. Multiple logistic regression analyzed predictors of implementing guideline activities. Mean age was 51.3 years, with the majority male (64.4%) and non-Hispanic White (63.9%). Nearly all physicians reported asking patients if they smoke (95.6%) and advising to stop (94.8%), slightly fewer assessed readiness to quit (86.5%), and only a minority assisted with a quit plan (27.4%), or arranged follow-up (18.6%). Only 18% reported using the U.S. Public Health Service Guidelines in clinical practice. Time-related factors were the most common barriers (53.4%), with patient factors (36.9%) and financial/resource factors (35.1%) cited less frequently. Predictors of implementing aspects of the 5A’s included physician awareness and utilization of the U.S. Public Health Service guidelines, specialty, and to a smaller degree graduating prior to 1990, not reporting time as a barrier, patient barriers, sex, and higher perceived effectiveness of pharmacotherapy. This national survey highlights the need for increased implementation of all aspects of the latest guidelines for evidence-based tobacco treatments, including community-based resources.
登录
查看更多内容
影响因子:
4.7
作者:
Conroy, MB;Majchrzak, NE;Rigotti, NA
通讯作者:
Rigotti, NA
DOI:
10.3205/000282
发表时间:
2020-01-01
期刊:
German medical science : GMS e-journal
影响因子:
--
作者:
Bauer, Anna;Brenner, Lorena;Bals, Robert
通讯作者:
Bals, Robert
DOI:
10.15585/mmwr.mm6946a4
发表时间:
2020-11-20
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Cornelius ME;Wang TW;Jamal A;Loretan CG;Neff LJ
通讯作者:
Neff LJ
影响因子:
4.7
作者:
Tong, Elisa K.;Strouse, Richard;Schroeder, Steven A.
通讯作者:
Schroeder, Steven A.
影响因子:
2.3
作者:
Steinberg, Michael B.;Alvarez, Michelle S.;Cantor, Joel C.
通讯作者:
Cantor, Joel C.